Keywords: بیماری پارکینسون; Multiple system atrophy; Parkinson's disease; Speech; Acoustic analysis; Perceptual analysis;
مقالات ISI بیماری پارکینسون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بیماری پارکینسون; Levodopa; Parkinson's disease; Off period; Dry powder inhalation; Cyclops;
Keywords: بیماری پارکینسون; ADC; apparent diffusion coefficients; ATR; anterior thalamic radiation; CST; corticospinal tract; DTI; diffusion tensor image; DWI; diffusion weighted image; FA; fractional anisotropy; IFOF; inferior fronto-occipital fasciculus; MCP; middle cerebellar ped
Keywords: بیماری پارکینسون; Subthalamic nucleus; Deep brain stimulation; Parkinson's disease; Delay discounting; Iowa Gambling Task;
Keywords: بیماری پارکینسون; Parkinson's disease; Lateralization of linguistic functions; Deep brain stimulation; Spontaneous language production; Asymmetric dopamine depletion;
Keywords: بیماری پارکینسون; ANOVA; analysis of variance; BBB; blood-brain barrier; GDNF; glia-derived neurotrophic factor; GLP-1; glucagon-like peptide 1; MPP+; 1-methyl-4-phenylpyridinium; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD; Parkinson's disease; TH; tyrosine
Keywords: بیماری پارکینسون; Anxiety; Autism; Coherence; Coupling; Depression; Gamma; Network dynamics; Neural oscillations; Parkinson's disease; Schizophrenia; Theta;
Keywords: بیماری پارکینسون; Atomoxetine; impulsivity; noradrenaline; Parkinson's disease; response inhibition; SSRT;
Keywords: بیماری پارکینسون; Parkinson's disease; Vision; Veering; Motor;
Keywords: بیماری پارکینسون; Parkinson's disease; Automatic control; Attentional control; Bradykinesia; Basal ganglia;
Keywords: بیماری پارکینسون; Parkinson's disease; Levodopa; Postural control; Electrovestibulography; Symptomatology; Biomarker;
Keywords: بیماری پارکینسون; ASAs; anticipatory synergy adjustments; DPMs; distributed processing modules; ICS; impaired control of stability; PD; Parkinson's disease; UCM; uncontrolled manifold; UPDRS; Unified PD Rating Scale; stability; synergy; anticipatory synergy adjustments;
Keywords: بیماری پارکینسون; Induced pluripotent stem cell; Neurological diseases; Parkinson's disease; Neuron;
Keywords: بیماری پارکینسون; AIMP2; aminoacyl-tRNA synthetase complex-interacting multifunctional protein 2; CTX; cerebral cortex; Chow-SN; SN of chow-diet mice; DA; dopaminergic neurons; FBP1; far-upstream element (FUSE) binding protein 1; GO; gene ontology; HFD; high-fat diet; HRP;
Keywords: بیماری پارکینسون; AD; Alzheimer's disease; ANOVA; analysis of variance; EDTA; ethylenediaminetetraacetic acid; HD; Huntington's disease; HDAC; histone deacetylase; OPA1; optic atrophy type 1; PD; Parkinson's disease; ROS; reactive oxygen species; sulforaphane; iron;
Keywords: بیماری پارکینسون; 5-HT; 5-hydroxytryptamine; 5-HT7; serotonin7; 6-OHDA; 6-hydroxydopamine; DA; dopamine; DMSO; dimethyl sulfoxide; FST; forced swim test; MFB; medial forebrain bundle; mPFC; medial prefrontal cortex; NA; noradrenaline; PD; Parkinson's disease; PrL; prelim
Keywords: بیماری پارکینسون; Parkinson's disease; Older adult; Medicine; Formulation; Dosage form;
Keywords: بیماری پارکینسون; ANOVA; analysis of variance; Ccl2; chemokine (C-C motif) ligand 2; cDNA; complementary deoxyribonucleic acid; Cu; copper; Dmt1; divalent metal transporter 1; Fe; iron; FESEM; field emission scanning electron microscopy; Gfap; glial fibrillary acidic pro
Keywords: بیماری پارکینسون; LARS-e; Lille Apathy Rating Scale - extended version; AI; Action Initiation; ER; Emotional Responsiveness; IC; Intellectual Curiosity; SA; Self-Awareness; DASS; Depression, Anxiety, Stress Scales; SHAPS; Snaith-Hamilton Pleasure Scale; MVC; Maximum Vo
Keywords: بیماری پارکینسون; ARND; age related neurodegenerative diseases; AD; Alzheimer's disease; ALS/PDC; amyotrophic lateral sclerosis-Parkinsonism dementia complex of Guam; BBB; blood brain barrier; BMAA; β-methylamino-l-alanine; CNS; central nervous system; CSF; cerebrospina
Keywords: بیماری پارکینسون; DAMP; danger-associated molecular pattern; GWAS; genome-wide association studies; IL; interleukin; iNOS; inducible nitric oxide synthase; iTreg; inflammatory suppressing inducible regulatory T cells; LPS; lipopolysaccharide; MHC; major histocompatibility;
Keywords: بیماری پارکینسون; 5-HIAA; 5-hydroxyindolacetic acid; 5-HT; serotonin; 6-OHDA; 6-hydroxydopamine; AIMs; Abnormal involuntary movements; ARC; activity-regulated cytoskeletal-associated protein; DA; dopamine; DOPAC; 3,4-dihydroxyphenylacetic acid; EDTA; ethylenediaminetetraac
Keywords: بیماری پارکینسون; 6-OHDA; 6-hydroxydopamine; ANOVA; analysis of variance; BSA; bovine serum albumin; BT; beam test; CAT; catalase enzyme; CE; corticospinal pathway; CSB; circular small beam; CT; cylinder test; EA; enzyme activity; iNOS; inducible NO synthase; i.p.; intrape
Keywords: بیماری پارکینسون; 6-OHDA; 6-hydroxydopamine; ANOVA; analysis of variance; BDNF; brain-derived neurotrophic factor; DA; dopaminergic; DMEM; Dulbecco's modified Eagle's medium; E12; embryonic day 12; FCS; fetal calf serum; FGF-2; fibroblast growth factor 2; GDNF; glial c
Keywords: بیماری پارکینسون; AA; acrylic acid; Apo; apolipoprotein; BBB; blood-brain barrier; BCEC; brain capillary endothelial cells; BDNF; brain-derived neurotrophic factor; CNS; central nervous system; CNT; carbon nanotubes; FDA; U.S. Food and Drug Administration; GFAP; glial fibr
Keywords: بیماری پارکینسون; DBS; deep brain stimulation; EEG; electroencephalography; ERD; event-related desynchronization; iCOH; imaginary part of coherency; iCOHd; detectability of imaginary part of coherency; iCOHdav; detectability of imaginary part of coherency averaged within d
Keywords: بیماری پارکینسون; Aβ; amyloid beta; AD; Alzheimer's disease; ADDL; amyloid-β-derived diffusible ligand; ALS; amyotrophic lateral sclerosis; ApoE; apolipoprotein E; ART; antiretroviral therapy; BBB; blood-brain barrier; CNS; central nervous system; CSF; cerebral spina
Keywords: بیماری پارکینسون; AKT; protein kinase B; BBB; blood-brain barrier; BDNF; brain-derived neurotrophic factor; CNS; central nervous system; DA; dopamine; DAB; diaminobenzidine; 78-DHF; 7,8-dihydroxyflavone; DL; dorsolateral; ECF; enhanced chemifluorescence; EDTA; ethylenedi
Keywords: بیماری پارکینسون; Parkinson's disease; Nonmotor symptoms; Exploratory factor analysis; Sleep; Attention; Mood;
Keywords: بیماری پارکینسون; Droxidopa; Parkinson's disease; Motor fuction; Add-on; Norepinnehrine; CGI; Clinical Global Impression rating score; FAS; full analysis set; ITT; intent-to-treat; l-DOPA; Levodopa; l-DOPS; l-threo-3,4-dihydroxyphenylserine; NE; norepinnehrine; PD; Parki
Keywords: بیماری پارکینسون; Parkinson's disease; Inflammation; Chlorpyrifos; Dopaminergic neuron; Mitogen-activated protein kinase; Nuclear factor-κB;
Keywords: بیماری پارکینسون; Parkinson's disease; Autoantibodies; Diagnosis; Protein microarrays; Biomarkers;
Keywords: بیماری پارکینسون; Mitochondria; Parkinson's disease; Dopamine; Bioenergetics; Neurodegeneration;
Keywords: بیماری پارکینسون; Dyskinesia; Motor performance; Parkinson's disease; Repetitive transcranial magnetic stimulation; Supplementary motor area;
Keywords: بیماری پارکینسون; Fluorescence-based biosensor; Kinase activity assay; LRRK2; Parkinson's disease; Inhibitor;
Keywords: بیماری پارکینسون; Deep brain stimulation; Encephalopathy; Hospital stay; Medication errors; Parkinson's disease;
Keywords: بیماری پارکینسون; Health-related quality of life; Non-motor symptoms; Parkinson's disease;
Keywords: بیماری پارکینسون; Dysfunctional beliefs; Parkinson's disease; Sleep;
Keywords: بیماری پارکینسون; Parkinson's disease; Cancer; Association; Risk; Malignancy;
Keywords: بیماری پارکینسون; Parkinson's disease; Parkin mutations; Mitochondrial dysfunction; Fibroblasts; Muscle;
Keywords: بیماری پارکینسون; Parkinson's disease; Lithium; Striatum; Neuroinflammation; Behavior; Astrocyte;
Keywords: بیماری پارکینسون; EQ-5D; happiness; Parkinson's disease; subjective well-being;
Keywords: بیماری پارکینسون; ANOVA; analysis of variance; DTE; dual-task effect; H&Y; Hoehn and Yahr; MDS-UPDRS; Movement Disorder Society Unified Parkinson's Disease Rating Scale; PD; Parkinson's disease; SOS; Systematic Screening of Handwriting Difficulties; Parkinson's disea
Keywords: بیماری پارکینسون; 2330; Parkinson's disease; Reaching; Electromyography; Postural perturbation;
Keywords: بیماری پارکینسون; 2330; 2343; 3720; Embodied cognition; Action simulation; Mental transformation; Parkinson's disease; Mental rotation; Motor imagery;
Keywords: بیماری پارکینسون; Hip fracture; bisphosphonate; Parkinson's disease; stroke;
Keywords: بیماری پارکینسون; Tremor; Parkinson's disease; Essential tremor; Attention; Distraction; Classification;
Keywords: بیماری پارکینسون; Sex differences; Parkinson's disease; Nigrostriatal dopaminergic pathways; Sex hormones; Neuroprotection;
Keywords: بیماری پارکینسون; Actigraphy; Cognition; Neuropsychological; Parkinson's disease; Sleep;
Keywords: بیماری پارکینسون; Autonomic dysfunction; Parkinson's disease; Hoehn & Yahr stage; Severity;